Comecer will attend
EANM '26

Join us at the EANM Annual Congress and discover how innovation in radiopharmaceutical processing is transforming nuclear medicine.

This year again, Comecer will be there, contributing to the ongoing evolution of technologies that support diagnosis and targeted therapies. As the field continues to grow, driven by new radiopharmaceuticals and theranostic approaches, the need for safe, efficient, and compliant processes is becoming increasingly critical.

From radioisotope production to dispensing and administration, nuclear medicine relies on highly specialized processes and technologies. Comecer supports this entire workflow with advanced solutions designed to ensure:

• Operator safety and radioprotection

• Aseptic processing in compliance with GMP standards

• Precision and repeatability in radiopharmaceutical handling

• Flexibility to adapt to evolving therapies and isotopes

These elements are essential to enable the development and delivery of innovative treatments, especially in emerging areas such as targeted alpha therapies (TAT) and radioligand therapies. 

Our radiopharma team will be available throughout the event to share insights, answer your questions, and support you in identifying the best solutions for your applications.